45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,925
Insurances with rates
23
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
10022165_1
$630,773
INJECTION, VUTRISIRAN, 1 MG
Gross
$630,773
10105078_1
$123,087
INJECTION, PEGLOTICASE, 1 MG
Gross
$123,087
10016945_1
$119,074
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, THERAPEUTIC, 1 MILLICURIE
Gross
$119,074
10048137_1
$96,480
INJECTION, TARLATAMAB-DLLE, 1 MG
Gross
$96,480
10016785_1
$91,410
JOINT DEVICE (IMPLANTABLE)
Gross
$91,410
10102746_1
$84,891
INJECTION, EFGARTIGIMOD ALFA, 2 MG AND HYALURONIDASE-QVFC
Gross
$84,891
10182280_1
$69,209
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT
Gross
$69,209
10017528_10
$59,749
INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG
Gross
$59,749
10017528_3
$59,749
INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG
Gross
$59,749
10099876_1
$57,862
INJECTION, GUSELKUMAB, 1 MG
Gross
$57,862
10063778_1
$55,895
INJECTION, UBLITUXIMAB-XIIY, 1MG
Gross
$55,895
10116238_1
$54,707
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chambe
Gross
$54,707
10149093_1
$54,155
ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE)
Gross
$54,155
10116239_1
$50,616
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial
Gross
$50,616
10116240_1
$50,616
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial
Gross
$50,616
10116241_1
$50,616
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial
Gross
$50,616
10116242_1
$50,616
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial
Gross
$50,616
10139899_1
$50,084
GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), HIGH FREQUENCY, WITH RECHARGEABLE BATTERY AND CHARGING SYS
Gross
$50,084
10143417_1
$49,683
CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE)
Gross
$49,683
10100228_1
$47,292
INJECTION, SODIUM THIOSULFATE (PEDMARK), 100 MG
Gross
$47,292
10182279_1
$47,237
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT
Gross
$47,237
10180289_1
$46,173
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH
Gross
$46,173
10013434_1
$44,923
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE
Gross
$44,923
10116254_1
$44,706
Insertion of permanent single-chamber leadless pacemaker for pacing the right upper heart chamber us
Gross
$44,706
10182282_1
$44,040
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH
Gross
$44,040
10021172_1
$42,816
CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$42,816
10024626_1
$42,771
CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA)
Gross
$42,771
10115625_1
$41,268
GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM
Gross
$41,268
10138675_1
$41,265
CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$41,265
10113333_1
$41,068
GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), INCLUDES CLOSED FEEDBACK LOOP LEADS AND ALL IMPLANTABLE CO
Gross
$41,068
10120786_1
$40,764
CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$40,764
10112064_1
$40,066
IMPLANTABLE NEUROSTIMULATOR, PULSE GENERATOR, ANY TYPE
Gross
$40,066
10017527_10
$39,833
INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG
Gross
$39,833
10017527_3
$39,833
INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG
Gross
$39,833
10115629_1
$39,205
GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM
Gross
$39,205
10101318_1
$39,155
PACEMAKER, DUAL CHAMBER, RATE-RESPONSIVE (IMPLANTABLE)
Gross
$39,155
10017480_1
$38,825
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL/PERONEAL ARTERY(IES); WITH INTRAVASCUL
Gross
$38,825
10017482_1
$38,629
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE
Gross
$38,629
10120909_1
$38,143
Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chambe
Gross
$38,143
10104125_1
$38,130
USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG
Gross
$38,130
10180291_1
$37,695
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH
Gross
$37,695
10138805_1
$37,352
CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$37,352
10138730_10
$36,743
INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG
Gross
$36,743
10138730_3
$36,743
INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG
Gross
$36,743
10182278_1
$35,540
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT
Gross
$35,540
10116249_1
$34,200
Insertion of pacemaker pulse generator with existing dual leads
Gross
$34,200
10013433_1
$34,017
REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE
Gross
$34,017
10139918_1
$33,493
JOINT DEVICE (IMPLANTABLE)
Gross
$33,493
10039575_1
$33,356
CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE)
Gross
$33,356
10126583_1
$33,055
GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), NON-RECHARGEABLE
Gross
$33,055
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 10022165_1 | INJECTION, VUTRISIRAN, 1 MG | $630,773 | $630,773 | — | — | 46 |
| 10105078_1 | INJECTION, PEGLOTICASE, 1 MG | $123,087 | $123,087 | — | — | 46 |
| 10016945_1 | LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, THERAPEUTIC, 1 MILLICURIE | $119,074 | $119,074 | — | — | 46 |
| 10048137_1 | INJECTION, TARLATAMAB-DLLE, 1 MG | $96,480 | $96,480 | — | — | 41 |
| 10016785_1 | JOINT DEVICE (IMPLANTABLE) | $91,410 | $91,410 | — | — | 28 |
| 10102746_1 | INJECTION, EFGARTIGIMOD ALFA, 2 MG AND HYALURONIDASE-QVFC | $84,891 | $84,891 | — | — | 41 |
| 10182280_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT | $69,209 | $69,209 | — | — | 41 |
| 10017528_10 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $59,749 | $59,749 | — | — | 46 |
| 10017528_3 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $59,749 | $59,749 | — | — | 25 |
| 10099876_1 | INJECTION, GUSELKUMAB, 1 MG | $57,862 | $57,862 | — | — | 46 |
| 10063778_1 | INJECTION, UBLITUXIMAB-XIIY, 1MG | $55,895 | $55,895 | — | — | 46 |
| 10116238_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chambe | $54,707 | $54,707 | — | — | 46 |
| 10149093_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $54,155 | $54,155 | — | — | 28 |
| 10116239_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $50,616 | $50,616 | — | — | 46 |
| 10116240_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $50,616 | $50,616 | — | — | 46 |
| 10116241_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $50,616 | $50,616 | — | — | 46 |
| 10116242_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial | $50,616 | $50,616 | — | — | 46 |
| 10139899_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), HIGH FREQUENCY, WITH RECHARGEABLE BATTERY AND CHARGING SYS | $50,084 | $50,084 | — | — | 28 |
| 10143417_1 | CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE) | $49,683 | $49,683 | — | — | 28 |
| 10100228_1 | INJECTION, SODIUM THIOSULFATE (PEDMARK), 100 MG | $47,292 | $47,292 | — | — | 46 |
| 10182279_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT | $47,237 | $47,237 | — | — | 41 |
| 10180289_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH | $46,173 | $46,173 | — | — | 41 |
| 10013434_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE | $44,923 | $44,923 | — | — | 46 |
| 10116254_1 | Insertion of permanent single-chamber leadless pacemaker for pacing the right upper heart chamber us | $44,706 | $44,706 | — | — | 41 |
| 10182282_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH | $44,040 | $44,040 | — | — | 41 |
| 10021172_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $42,816 | $42,816 | — | — | 28 |
| 10024626_1 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $42,771 | $42,771 | — | — | 28 |
| 10115625_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM | $41,268 | $41,268 | — | — | 28 |
| 10138675_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $41,265 | $41,265 | — | — | 28 |
| 10113333_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), INCLUDES CLOSED FEEDBACK LOOP LEADS AND ALL IMPLANTABLE CO | $41,068 | $41,068 | — | — | 28 |
| 10120786_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $40,764 | $40,764 | — | — | 28 |
| 10112064_1 | IMPLANTABLE NEUROSTIMULATOR, PULSE GENERATOR, ANY TYPE | $40,066 | $40,066 | — | — | 41 |
| 10017527_10 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $39,833 | $39,833 | — | — | 46 |
| 10017527_3 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $39,833 | $39,833 | — | — | 25 |
| 10115629_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), WITH RECHARGEABLE BATTERY AND CHARGING SYSTEM | $39,205 | $39,205 | — | — | 28 |
| 10101318_1 | PACEMAKER, DUAL CHAMBER, RATE-RESPONSIVE (IMPLANTABLE) | $39,155 | $39,155 | — | — | 28 |
| 10017480_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL/PERONEAL ARTERY(IES); WITH INTRAVASCUL | $38,825 | $38,825 | — | — | 46 |
| 10017482_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE | $38,629 | $38,629 | — | — | 46 |
| 10120909_1 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chambe | $38,143 | $38,143 | — | — | 46 |
| 10104125_1 | USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG | $38,130 | $38,130 | — | — | 33 |
| 10180291_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, TIBIAL AND PERONEAL VASCULAR TERRITORY, WITH | $37,695 | $37,695 | — | — | 41 |
| 10138805_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $37,352 | $37,352 | — | — | 28 |
| 10138730_10 | INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG | $36,743 | $36,743 | — | — | 46 |
| 10138730_3 | INJECTION, CABOTEGRAVIR AND RILPIVIRINE, 2MG/3MG | $36,743 | $36,743 | — | — | 25 |
| 10182278_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, FEMORAL AND POPLITEAL VASCULAR TERRITORY, WIT | $35,540 | $35,540 | — | — | 41 |
| 10116249_1 | Insertion of pacemaker pulse generator with existing dual leads | $34,200 | $34,200 | — | — | 46 |
| 10013433_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, LOWER EXTREMITY ARTERY(IES), EXCEPT TIBIAL/PE | $34,017 | $34,017 | — | — | 46 |
| 10139918_1 | JOINT DEVICE (IMPLANTABLE) | $33,493 | $33,493 | — | — | 28 |
| 10039575_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $33,356 | $33,356 | — | — | 28 |
| 10126583_1 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), NON-RECHARGEABLE | $33,055 | $33,055 | — | — | 28 |
Showing top 50 of 5,925 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.